Research Topics
| Peter BachSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Lung cancer screeningPeter B Bach
Memorial Sloan Kettering Cancer Center, New York, New York10021, USA
J Natl Compr Canc Netw 6:271-5. 2008..This general recommendation could change if randomized trials examining CT screening suggest that its benefits outweigh its harms...- Screening for lung cancer: the guidelinesPeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021, USA
Chest 123:83S-88S. 2003..We recommend that individuals should only be screened with LDCT in the context of well-designed clinical trials... - Variations in lung cancer risk among smokersPeter B Bach
The Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Natl Cancer Inst 95:470-8. 2003..We sought to determine whether the risk of lung cancer varies predictably among smokers... - Resurrecting treatment histories of dead patients: a study design that should be laid to restPeter B Bach
The Health Outcomes Research Group, The Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
JAMA 292:2765-70. 2004..We conclude that studying care received prior to death can lead to invalid conclusions about the quality or type of care provided to dying patients... - Benchmarking lung cancer mortality rates in current and former smokersPeter B Bach
Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 221, New York, NY 10021, USA
Chest 126:1742-9. 2004..The model is intended for use in analyzing a population of subjects who are undergoing lung cancer screening or receiving lung cancer chemoprevention, to determine whether the intervention has altered lung cancer mortality... - Racial disparities and site of carePeter B Bach
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021, USA
Ethn Dis 15:S31-3. 2005..Determining the relative contribution of each of these mechanisms to racial and ethnic disparities in health care should be a priority... 
Is our natural-history model of lung cancer wrong?Peter B Bach
Health Outcomes Group, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Lancet Oncol 9:693-7. 2008..If true, these findings have potentially important implications for the development and assessment of new lung-cancer screening approaches...- Costs of cancer care: a view from the centers for Medicare and Medicaid servicesPeter B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 25:187-90. 2007..Understanding these three aspects of cancer care financing can help clarify what Medicare is capable of doing to control the rising costs that are occurring in cancer today... - Episode-based payment for cancer care: a proposed pilot for MedicarePeter B Bach
Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York City, NY, USA
Health Aff (Millwood) 30:500-9. 2011..If successful, the concept could be expanded to encompass longer time periods, other cancer diagnoses, and additional care components... - Screening for lung cancer: a review of the current literaturePeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 221, New York, NY 10021, USA
Chest 123:72S-82S. 2003..To review the available data on the early detection of lung cancer, with a focus on three technologies: chest x-ray (CXR), sputum cytology, and low-dose CT (LDCT) scanning... - Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitationsPeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Med Care 40:IV-19-25. 2002..Finally, they describe the available data on date of death, and explain why confidence in these measures is justified... - Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantationP B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Blood 98:3234-40. 2001..The presence of this feature may justify the recommendation to withdraw life-sustaining measures... - Physician visits prior to treatment for clinically localized prostate cancerThomas L Jang
Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York, USA
Arch Intern Med 170:440-50. 2010..We evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice... - The effect of clustering of outcomes on the association of procedure volume and surgical outcomesKatherine S Panageas
Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Ann Intern Med 139:658-65. 2003..Thus, in volume-outcome studies, the degree of clustering of outcomes should be characterized because it may provide insight into variations in quality of care... - Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancerDeborah Schrag
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 20:3999-4005. 2002..Nevertheless, patients may receive this treatment despite its uncertain benefit. The objective of this study was to determine the extent to which adjuvant chemotherapy is used for patients with stage II colon cancer... - Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)Peter B Bach
Memorial Sloan Kettering Cancer Center, 307 East 63rd St, Third Floor, New York, NY 10021, USA
Chest 132:69S-77S. 2007..Because early-stage disease can be successfully treated, a screening technique that can detect lung cancer before it has spread might be useful in decreasing lung cancer mortality... - Trends in the use of postoperative radiotherapy for resected non-small-cell lung cancerJustin E Bekelman
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 66:492-9. 2006..Yet practice guidelines differ in their recommendations with regard to PORT use. We examine temporal trends in PORT use before and after the 1998 meta-analysis... - Fragmentation of care for frequently hospitalized urban residentsDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, and the Department of Health Policy, Mount Sinai School of Medicine, New York, New York 10021, USA
Med Care 44:560-7. 2006..Fragmentation across sites of care may impede efficient healthcare delivery... 
Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosisElena B Elkin
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
J Natl Cancer Inst 100:1013-21. 2008..We compared rates of voluntary disenrollment from Medicare managed care to traditional fee-for-service Medicare among Medicare managed care enrollees with and without a cancer diagnosis...- Survival of blacks and whites after a cancer diagnosisPeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
JAMA 287:2106-13. 2002..Differences in treatment, stage at presentation, and mortality from other diseases should represent the primary targets of research and interventions designed to reduce disparities in cancer outcomes... - Variations in morbidity after radical prostatectomyColin B Begg
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York 10021, USA
N Engl J Med 346:1138-44. 2002..Recent studies of surgery for cancer have demonstrated variations in outcomes among hospitals and among surgeons. We sought to examine variations in morbidity after radical prostatectomy for prostate cancer... - Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancerYelena Y Janjigian
Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA
Cancer 116:670-5. 2010.... - Geographic access and the use of screening mammographyElena B Elkin
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Med Care 48:349-56. 2010..Inadequate mammography resources in some areas may impair access to this technology. We assessed the relationship between availability of mammography machines and the use of screening... - Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare populationDeborah Schrag
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Urology 65:1118-25. 2005..To describe the population-based patterns of care among patients with muscle-invasive bladder cancer... - Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resectionDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Department of Medicine, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Ann Surg 236:583-92. 2002..To compare surgeon and hospital procedure volume as predictors of outcomes for patients with rectal cancer... - Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resectionDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Surg Oncol 83:68-78; discussion 78-9. 2003..However, the importance of surgeon case volume as a determinant of outcome has been less well studied, and it is unclear whether hospital or surgeon volume is the more powerful predictor of outcomes... - Primary care physicians who treat blacks and whitesPeter B Bach
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, USA
N Engl J Med 351:575-84. 2004..Further research should be conducted to address the extent to which these differences may be responsible for disparities in health care... - Clinical prediction rule for atrial fibrillation after coronary artery bypass graftingDavid Amar
Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center and Weill Medical College of Cornell University, New York, New York 10021, USA
J Am Coll Cardiol 44:1248-53. 2004.... - Adherence to surveillance among patients with superficial bladder cancerDeborah Schrag
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Natl Cancer Inst 95:588-97. 2003..We examined the degree to which bladder cancer patients undergo the recommended surveillance procedures and identified patient and primary care provider characteristics associated with nonadherence to these recommendations... - Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sourcesDeborah Schrag
Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Med Care 40:IV-96-103. 2002.... - Computed tomography screening and lung cancer outcomesPeter B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
JAMA 297:953-61. 2007..Randomized controlled trials assessing CT screening are currently under way... - Impact of infection by vancomycin-resistant Enterococcus on survival and resource utilization for patients with leukemiaPeter B Bach
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Infect Control Hosp Epidemiol 23:471-4. 2002..Compared with their matched controls (n = 45), cases (n = 23) had 22% greater total charges and shorter survival (P = .04). These findings substantiate the need for aggressive interventions to prevent VRE transmission... - The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinomaNabil P Rizk
Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Am Coll Surg 198:42-50. 2004..CONCLUSIONS: Technical complications have a large negative impact on survival after esophagogastrectomy for cancer. Strategies to optimize surgical technique and minimize complications should improve outcomes in this cancer operation... - A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvementPeter A Learn
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Med Care 48:1041-9. 2010..The degree to which practice patterns and outcomes have changed over that time period is unclear... - Radiation therapy facilities in the United StatesLeslie K Ballas
The Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 66:1204-11. 2006.... - Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplastyStephen Lyman
Hospital for Special Surgery, New York, NY 10021, USA
Clin Orthop Relat Res 448:152-6. 2006..LEVEL OF EVIDENCE: Prognostic study, Level II (retrospective study). See the Guidelines for Authors for a complete description of levels of evidence... - Response to "CT screening for lung cancer: update 2007"Peter B Bach
Oncologist 13:608-9; author reply 610-2. 2008 - Delivery of preventive services to older adults by primary care physiciansHoangmai H Pham
Center for Studying Health System Change, Washington, DC 20024, USA
JAMA 294:473-81. 2005..Rates of preventive services remain below national goals... - Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizationsCharles L Bennett
VA Midwest Center for Health Services and Policy Research, Department of Veterans Affairs, Chicago Healthcare System Lakeside Division, Chicago, USA
J Clin Oncol 21:937-41. 2003..ASCO members and Health Maintenance Organizations (HMOs) were surveyed on the value and implementation of ASCO guidelines. In this article, we summarize our findings... - Do surgical quality gaps cause healthcare disparities?Peter B Bach
Med Care 46:889-92. 2008 - CT screening for lung cancerPeter B Bach
Cleve Clin J Med 74:769-70; author reply 770. 2007 - Risk charts: putting cancer in contextPeter B Bach
J Natl Cancer Inst 94:1584-5; author reply 1585-6. 2002 - Potentially avoidable hospitalizations for COPD and pneumonia: the role of physician and practice characteristicsAnn S O'Malley
Center for Studying Health System Change, Washington, DC 20024 2512, USA
Med Care 45:562-70. 2007..Hospitalizations for bacterial pneumonia and chronic obstructive pulmonary disease (COPD) occur frequently, but many are potentially avoidable... - Care patterns in Medicare and their implications for pay for performanceHoangmai H Pham
Center for Studying Health System Change, Washington, DC 20024, USA
N Engl J Med 356:1130-9. 2007.... - Re: All-cause mortality in randomized trials of cancer screeningColin B Begg
J Natl Cancer Inst 94:863-4; author reply 865-6. 2002 - Validation of a model of lung cancer risk prediction among smokersKathleen A Cronin
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
J Natl Cancer Inst 98:637-40. 2006..57 (95% CI = 0.49 to 0.67) for the age groups 50-54, 55-59, 60-64, and 65-69 years, respectively. Periodic radiographic screening in the ATBC Study may explain why slightly more cancers were observed than expected from the Bach model... - Cost sharing for health care--whose skin? Which game?Peter B Bach
N Engl J Med 358:411-3. 2008 - Using practice guidelines to assess cancer care qualityPeter B Bach
J Clin Oncol 23:9041-3. 2005 - CT screening for lung cancerPeter B Bach
N Engl J Med 356:744; author reply 746-7. 2007 - Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly populationJoan L Warren
Applied Research Program, National Cancer Institute, Bethesda, Maryland 20892 7344, USA
Med Care 40:IV-3-18. 2002..The use of this database to study cancer screening, treatment, outcomes, and costs has grown in recent years... - The epidemiology and costs of chronic critical illnessShannon S Carson
Division of Pulmonary and Critical Care Medicine, University of North Carolina, 420 Burnett Womack Building, CB 7020, Chapel Hill, NC 27599, USA
Crit Care Clin 18:461-76. 2002..Efforts should continue to learn how to identify patients at high risk for CCI and poor outcome so that expensive resources can be managed effectively, and patient-provider decision making can be better informed... - State expenditures for tobacco-control programs and the tobacco settlementCary P Gross
Department of Medicine, Yale University School of Medicine, Primary Care Center, New Haven, Conn 06520, USA
N Engl J Med 347:1080-6. 2002..Despite controversy surrounding the use of funds arising from settlement agreements with the tobacco industry, little is known about the role of these funds in expenditures for state tobacco-control programs... - A prescription for a modern Medicare programPeter B Bach
Dr. Bach is a senior adviser and Dr. McClellan the administrator of the Centers for Medicare and Medicaid Services, Washington, D.C
N Engl J Med 353:2733-5. 2005 - Survival in women after diagnosis of lung cancerPeter B Bach
JAMA 297:153; author reply 153-4. 2007 - Lung cancer in US women: a contemporary epidemicJyoti D Patel
Division of Hematology Oncology, Feinberg School of Medicine, Northwestern University, and the Robert H Lurie Comprehensive Cancer Center, Chicago, Ill 60611, USA
JAMA 291:1763-8. 2004..Finally, disseminating information about this epidemic may prevent a similar epidemic in other parts of the world where women are just now becoming addicted to tobacco... - Federal initiatives to support rapid learning about new technologiesSean R Tunis
Center for Medical Technology Policy, San Francisco, CA, USA
Health Aff (Millwood) 26:w140-9. 2007..The value of these efforts will depend on coordination among individuals and institutions in the public and private sectors; clarity about focus, purpose, and priorities; and adequate and reliable long-term funding... - Overdiagnosis in lung cancer: different perspectives, definitions, implicationsPeter B Bach
Thorax 63:298-300. 2008 - NCCN Task Force Report: Oral chemotherapySaul N Weingart
Dana Farber Cancer Institute
J Natl Compr Canc Netw 6:S1-14. 2008..To address these issues, the NCCN convened a multidisciplinary task force consisting of oncologists, nurses, pharmacists, and payor representatives to discuss the impact of the increasing use of oral chemotherapy... - The first months of the prescription-drug benefit--a CMS updatePeter B Bach
Centers for Medicare and Medicaid Services, Washington, DC, USA
N Engl J Med 354:2312-4. 2006
Research Grants
- UNDERSTANDING RACIAL DIFFERENCES--LUNG CANCER TREATMENTPeter Bach; Fiscal Year: 2003..Once identified, differences in the evaluative process undergone by black and white patients will be assessed, and the association between provider and patient race on receipt of surgery will be tested. ..
- A NEW FUNCTIONAL EVALUATION TOOL FOR CANCER CAREPeter Bach; Fiscal Year: 2004..4) Instrument assembly through analysis of results of reliability and validity testing, followed by dissemination of results. ..
- Roots of Health Disparities: The Quality of Primary CarePeter Bach; Fiscal Year: 2007..The significance of these findings would be that a singular approach to improving the quality of care provided by physicians should enhance care quality overall and reduce healthcare disparities. ..